Neurogenetics

Neurogenetics delves into how genetic factors impact neurological disorders such as Alzheimer's disease and dementia. In Alzheimer's, mutations in genes like APP, PSEN1, and PSEN2 heighten vulnerability by disrupting amyloid-beta processing and tau protein regulation. Meanwhile, dementia, encompassing various forms of cognitive decline, also shows genetic links, notably with the APOE gene variant ε4 increasing the risk of late-onset Alzheimer's. Studying these genetic nuances is crucial for early detection and personalized treatment approaches. Unraveling these genetic foundations not only deepens our understanding of disease mechanisms but also paves the way for tailored therapies and preventive strategies in the future.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China

Submit your abstract Today

Whatsapp